Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium and Riboflavin for Post-Concussion Headache
NCT06260072Phase 2Recruiting
- Sponsor
- University of Virginia
- Start
- Feb 2020
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in concussion (mTBI) and Headache, sponsored by University of Virginia. Primary endpoint: Headache Intensity and Duration at 14 days. Started Feb 2020; status: recruiting.
02
Conditions
concussion (mTBI)Headache
Beyond the preview
Go deeper on NCT06260072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06260072.